H. Rong

861 total citations
9 papers, 712 citations indexed

About

H. Rong is a scholar working on Pharmacology, Molecular Biology and Plant Science. According to data from OpenAlex, H. Rong has authored 9 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Molecular Biology and 2 papers in Plant Science. Recurrent topics in H. Rong's work include Hops Chemistry and Applications (4 papers), Cancer therapeutics and mechanisms (1 paper) and Powdery Mildew Fungal Diseases (1 paper). H. Rong is often cited by papers focused on Hops Chemistry and Applications (4 papers), Cancer therapeutics and mechanisms (1 paper) and Powdery Mildew Fungal Diseases (1 paper). H. Rong collaborates with scholars based in Belgium, United Kingdom and United States. H. Rong's co-authors include D. De Keukeleire, J Kalita, S. R. Milligan, Arne Heyerick, Luc De Cooman, Victoria Pocock, Max L. Deinzer, Jan F. Stevens, P. Sandra and Toufigh Gordi and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Investigative Dermatology and Reproduction.

In The Last Decade

H. Rong

8 papers receiving 670 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Rong Belgium 5 511 247 228 204 160 9 712
Atieh Hajirahimkhan United States 10 258 0.5× 256 1.0× 106 0.5× 59 0.3× 101 0.6× 13 526
Qingtao Yu China 13 143 0.3× 469 1.9× 206 0.9× 58 0.3× 34 0.2× 21 723
Nancy L. Booth United States 10 97 0.2× 277 1.1× 119 0.5× 34 0.2× 374 2.3× 11 738
Takashi Morota Japan 19 240 0.5× 634 2.6× 450 2.0× 64 0.3× 20 0.1× 29 873
Rosita Rodriguez‐Proteau United States 9 232 0.5× 145 0.6× 121 0.5× 62 0.3× 23 0.1× 12 429
Jer‐Min Lin Taiwan 12 236 0.5× 331 1.3× 219 1.0× 61 0.3× 40 0.3× 16 682
E C Krause United States 8 131 0.3× 115 0.5× 67 0.3× 42 0.2× 128 0.8× 9 333
Ikhlas Ahmad Khan United States 12 92 0.2× 286 1.2× 121 0.5× 53 0.3× 21 0.1× 22 457
Shun-Jen Tsai Taiwan 13 70 0.1× 238 1.0× 312 1.4× 78 0.4× 67 0.4× 21 580
Gilberto Santana-Rios United States 7 78 0.2× 106 0.4× 90 0.4× 85 0.4× 110 0.7× 8 364

Countries citing papers authored by H. Rong

Since Specialization
Citations

This map shows the geographic impact of H. Rong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Rong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Rong more than expected).

Fields of papers citing papers by H. Rong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Rong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Rong. The network helps show where H. Rong may publish in the future.

Co-authorship network of co-authors of H. Rong

This figure shows the co-authorship network connecting the top 25 collaborators of H. Rong. A scholar is included among the top collaborators of H. Rong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Rong. H. Rong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Rong, H., et al.. (2025). Integrative pan-cancer analysis of intratumoral microbial communities for biomarker discovery and diagnostic modeling. Journal of Translational Medicine. 23(1). 1347–1347. 1 indexed citations
3.
Slavin, Anthony, Veronica A. Campbell, Michele Mayo, et al.. (2020). 588 Identification of highly potent and selective Interleukin-1 receptor associated kinase 4 (IRAK4) degraders for the treatment of hidradenitis suppurativa. Journal of Investigative Dermatology. 140(7). S80–S80. 1 indexed citations
4.
Kelleher, Joseph F., Veronica A. Campbell, Jared Gollob, et al.. (2019). KYM‐001, A FIRST‐IN‐CLASS ORAL IRAK4 PROTEIN DEGRADER, INDUCES TUMOR REGRESSION IN XENOGRAFT MODELS OF MYD88‐MUTANT ABC DLBCL ALONE AND IN COMBINATION WITH BTK INHIBITION. Hematological Oncology. 37(S2). 129–129. 4 indexed citations
5.
Rong, H., et al.. (2016). Translational Pharmacokinetic/Pharmacodynamic Analysis of MYO‐029 Antibody for Muscular Dystrophy. Clinical and Translational Science. 9(6). 302–310. 26 indexed citations
6.
Kalita, J, Victoria Pocock, Arne Heyerick, et al.. (2002). Oestrogenic activity of the hop phyto-oestrogen, 8-prenylnaringenin. Reproduction. 123(2). 235–242. 162 indexed citations
7.
Milligan, S. R., J Kalita, Victoria Pocock, et al.. (2000). The Endocrine Activities of 8-Prenylnaringenin and Related Hop (Humulus lupulusL.) Flavonoids. The Journal of Clinical Endocrinology & Metabolism. 85(12). 4912–4915. 177 indexed citations
9.
Milligan, S. R., J Kalita, Arne Heyerick, et al.. (1999). Identification of a Potent Phytoestrogen in Hops (Humulus lupulus L.) and Beer. The Journal of Clinical Endocrinology & Metabolism. 84(6). 2249–2249. 298 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026